Page last updated: 2024-12-07
4,4',6-trimethylangelicin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4,4',6-trimethylangelicin: new monofunctional furocoumarin; potential agent for photochemotherapy of psoriasis; capable of photoreacting with DNA to a large extent forming only monoadducts; produces singlet oxygen to an insignificant extent; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 107731 |
CHEMBL ID | 173365 |
CHEBI ID | 82543 |
SCHEMBL ID | 17174622 |
MeSH ID | M0123355 |
Synonyms (24)
Synonym |
---|
4,6,9-trimethyl-2h-furo[2,3-h]chromen-2-one |
4,6,4'-trimethylangelicin |
4,6,9-trimethyl-2h-furo(2,3-h)-1-benzopyran-2-one |
4-hydroxy-beta,3,7-trimethyl-5-benzofuranacrylic acid delta-lactone |
4,4',6-trimethylangelicin |
4,6,9-trimethyl-2h-furo(2,3-h)(1)benzopyran-2-one plus ultraviolet a radiation |
4,4',6-trimethylangelicin plus ultraviolet a radiation |
brn 4467945 |
ccris 4277 |
4,4,6-trimethylangelicin |
2h-furo(2,3-h)-1-benzopyran-2-one, 4,6,9-trimethyl- |
2h-furo(2,3-h)(1)benzopyran-2-one, 4,6,9-trimethyl, plus ultraviolet a radiation |
90370-29-9 |
CHEMBL173365 |
chebi:82543 , |
4,6,9-trimethylfuro[2,3-h]chromen-2-one |
C19538 |
unii-t2myr3390l |
t2myr3390l , |
AKOS025119188 |
SCHEMBL17174622 |
DTXSID20238106 |
Q27156054 |
BB 0266510 |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
" In contrast with in vitro experiments, photobinding of CPZ to epidermal DNA/RNA was not found in vivo; apparently the bioavailability in the nucleus is very low." | ( Photobinding of 8-methoxypsoralen, 4,6,4'-trimethylangelicin and chlorpromazine to Wistar rat epidermal biomacromolecules in vivo. Beijersbergen van Henegouwen, GM; Caffieri, S; Dall'Acqua, F; Persons, CC; Schoonderwoerd, SA, 1991) | 0.28 |
" In this current study, cellular bioavailability of 8-MOP, TMA and CPZ was investigated in vitro, using low doses of UVA relevant for the clinical setting of ECP." | ( Phototoxicity, distribution and kinetics of association of UVA-activated chlorpromazine, 8-methoxypsoralen, and 4,6,4'-trimethylangelicin in Jurkat cells. Dobrucki, J; Rajwa, B; Sarna, T; Skrzeczyńska-Moncznik, J; van Henegouwen, GB; Wolnicka-Głubisz, A, 2005) | 0.33 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
furanocoumarin | Any furochromene that consists of a furan ring fused with a coumarin. The fusion may occur in different ways in give several isomers. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Bioassays (59)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID54115 | Compound was evaluated for the binding parameter by determining the number of nucleotides occluded by a bound angelicin (n) | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357671 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 1 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357658 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 10 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID16264 | Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89071 | Erythema induction by 8-methoxypsoralen (8-MOP) for comparison at dose of 4 J/cm e2 ultraviolet-A radiation in female patient; +++=very strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID619965 | Inhibition of NF-KB p50 subunit/DNA interaction after 20 mins by EMSA | 2011 | European journal of medicinal chemistry, Oct, Volume: 46, Issue:10 | Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects. |
AID88890 | Number of treatments at dose of 10 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID88892 | Number of treatments at dose of 6 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89080 | Erythema induction by the compound at dose of 8 J/cm e2 ultraviolet-A radiation in female patient; - = absent | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357654 | Induction of damage in salmon testes DNA at 100 uM in presence of 2.5 to 7.5 J/cm2 UVA irradiation by ethidium bromide dye-based agarose gel electrophoresis analysis | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID90073 | Pigmentation capacity of 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; + = moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90078 | Pigmentation capacity at dose of 10 J/cm e2 ultraviolet-A radiation in female patient; ++=strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID88893 | Number of treatments at dose of 8 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID16271 | Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357674 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 50 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID89078 | Erythema induction by the compound at dose of 4 J/cm e2 ultraviolet-A radiation in female patient; - = absent | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90079 | Pigmentation capacity at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; + = moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89070 | Erythema induction by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation in female patient; +++=very strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89073 | Erythema induction by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; +++ = very strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357668 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 10 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID16270 | Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357669 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 50 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357665 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 100 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357667 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 5 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID90083 | Pigmentation capacity at dose of 9 J/cm e2 ultraviolet-A radiation in female patient; +=moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89072 | Erythema induction by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; ++ = strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID16268 | Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID91202 | Number of treatments at dose of 6 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357663 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 10 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID16265 | Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID16266 | Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90071 | Pigmentation capacity of 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation in female patient; +=moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357660 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 100 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID89074 | Erythema induction by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation in female patient, +=moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID89077 | Erythema induction by the compound at dose of 10 J/cm e2 ultraviolet-A radiation in female patient; - = absent | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90074 | Pigmentation capacity of 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; ++ = strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID54807 | Compound was evaluated for the binding parameter by determining rate constant | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID54116 | Compound was evaluated for the frequency of the binding site that is the number of molecules bound to every nucleotide (1/n) | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357656 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 5 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID16269 | Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357662 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 5 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357670 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 100 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357659 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 50 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID88891 | Number of treatments at dose of 4 J/cm e2 ultraviolet-A radiation (female patient) | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID130473 | Compound was evaluated for 50% inhibition of DNA synthesis in Ehrlich ascites tumor cells by irradiation (365 nM) at 1.9 x 10e -5M incubated with [3H]thymidine at 37 degree C (p 0.05) | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90072 | Pigmentation capacity of 8-methoxypsoralen (8-MOP) for comparison at dose of 4 J/cm e2 ultraviolet-A radiation in female patient; - = absent | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357701 | Inhibition of NF-kappaB (unknown origin) assessed as decrease in NF-kappaB/DNA interaction at 12.5 to 100 uM using 32P-labeled target NF-kappaB double-stranded oligonucleotide after 30 mins by EMSA | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357666 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 1 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357657 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 1 uL/plate in absence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357672 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 5 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357675 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 100 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID89079 | Erythema induction by the compound at dose of 6 J/cm e2 ultraviolet-A radiation in female patient; - = absent | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357673 | Genotoxicity in Salmonella typhimurium TA100 assessed as revertant colonies at 10 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID54459 | Compound was evaluated for the association constant to an isolated site of DNA | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357661 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 1 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID90080 | Pigmentation capacity at dose of 8 J/cm e2 ultraviolet-A radiation in female patient; +++=very strong | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID90075 | Pigmentation capacity of 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation in female patient; +=moderate | 1984 | Journal of medicinal chemistry, Aug, Volume: 27, Issue:8 | 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. |
AID1357664 | Genotoxicity in Salmonella typhimurium TA98 assessed as revertant colonies at 50 uL/plate in presence of Sprague-Dawley rat S9 metabolic activation after 72 hrs by Ames test (Rvb = 1 No_unit) | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
AID1357702 | Induction of damage in salmon testes DNA at 100 uM in absence of 2.5 to 7.5 J/cm2 UVA irradiation by ethidium bromide dye-based agarose gel electrophoresis analysis | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (44)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (18.18) | 18.7374 |
1990's | 21 (47.73) | 18.2507 |
2000's | 5 (11.36) | 29.6817 |
2010's | 9 (20.45) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 10.95
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (10.95) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (2.27%) | 6.00% |
Case Studies | 2 (4.55%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 41 (93.18%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |